, although in late-stage heart failure the consensus finding is that I Ca,L declines (47). The unchanged level of I Ca,L in all but late-stage heart failure suggests that ventricular myocytes may have the capacity to homeostatically regulate I Ca,L .
), or Iso ϩ Ver via osmotic minipumps. To test for alterations of Ca 2ϩ channel complex components we performed real-time PCR and Western blot analysis on ventricle. In addition, cardiac myocytes (CMs) were dispersed and current was recorded in the whole cell configuration to evaluate ICa,L. Surprisingly, 24-to 48-h Ver increased CaV1.2 mRNA and protein and ICa,L current (Ver 11 Ϯ 1pA/pF vs. control 7 Ϯ 0.5pA/pF; P Ͻ 0.01). ICa,L from CMs in Ver mice showed no change in whole cell capacitance. To examine the in vivo effects of a physiologically relevant Ca 2ϩ channel agonist, we treated mice with Iso. Twenty-four-hour Iso infusion increased heart rate; CaV1.2-and CaV␤2 mRNA levels were constant, but the Ca 2ϩ channel subunit mRNA Rem was increased twofold. Cells isolated from 24-h Iso hearts showed no change in basal ICa,L density and diminished responsiveness to acute 1 M Iso. To further examine the homeostatic regulation of the Ca 2ϩ channel, we treated animals for 24 h with Iso ϩ Ver. The influence of Iso ϩ Ver was similar that of to Iso alone on Ca 2ϩ channel mRNAs and ICa,L, with the exception that it prevented the increase in Rem seen with Iso treatment. Long-term Ca 2ϩ channel blockade induces an increase of CaV1.2 mRNA and protein and significantly increases ICa,L. calcium channel blockade; ventricle; electrocardiogram; electrophysiology THE L-TYPE CA 2ϩ CHANNEL Ca V 1.2, the predominant voltagegated Ca 2ϩ channel in mammalian myocardium, provides the Ca 2ϩ flux necessary to initiate excitation-contraction coupling. A variety of conditions chronically regulate excitability via alterations of ion channel density. For example, changes in transient outward current levels across the ventricular wall can lead to arrhythmias (1) . Ca V 1.2 current (I Ca,L ) studies show less consistent results in a variety of disease models culminating in cellular hypertrophy (41) , although in late-stage heart failure the consensus finding is that I Ca,L declines (47) . The unchanged level of I Ca,L in all but late-stage heart failure suggests that ventricular myocytes may have the capacity to homeostatically regulate I Ca,L .
At the plasma membrane the Ca 2ϩ channel complex exists as a heteromultimer consisting of the ␣ 1 -subunit (Ca V 1.2), a cytosolic ␤-subunit (Ca V ␤ 2 ), and a covalently linked ␣ 2 ␦-subunit. Ca V 1.2, the pore-forming subunit, determines ion selectivity and voltage sensitivity and is a binding site for clinically used Ca 2ϩ channel blockers. Ca V ␤ coexpression primarily increases Ca V 1.2 current density in heterologous expression systems (4, 8, 21, 48) and in myocytes that overexpress Ca V ␤ (45). In addition to increasing functional expression, Ca V ␤s alter channel kinetics (29, 36, 44) and voltage dependence (5, 28, 39) . Among the accessory subunits, the Ca V ␤s are the only accessory proteins known to increase current density. In contrast to Ca V ␤, the ␣ 2 ␦-subunit has modest effects on channel current density and has variable effects on channel voltage dependence and kinetics (6, 25, 26, 31) . Overall, Ca V ␤ 2 in the heart serves as a positive regulator of I Ca,L (11) . We recently showed (13, 19) (22, 32, 38) ; however, little is known about the long-term cardiac effects of these drugs on cardiac myocytes. The primary objective of this study was to test the hypothesis that cardiac I Ca,L is homeostatically regulated. We postulated that Ca 2ϩ entering through the L-type channel provides feedback regulation. According to our hypothesis, decreasing I Ca,L , such as via chronic CCB, would elicit upregulation of I Ca,L . Conversely, stressors that acutely increase cytosolic Ca 2ϩ cause long-term decreases of I Ca,L as in heart failure (7, 46) . Our results demonstrate that long-term Ca 2ϩ channel blockade induces an increase of Ca V 1.2 mRNA and protein and significantly increases basal I Ca,L . In contrast, chronic ␤-adrenergic stimulation induces upregulation of positive and negative regulators of I Ca,L with no significant change in basal I Ca,L . Together, these results suggest that the main pore-forming subunit plays a greater role in determining I Ca,L than auxiliary subunits.
MATERIALS AND METHODS
Mini-osmotic pumps. Female or male ICR mice (12-14 wk of age) weighing between 25 and 30 g were anesthetized with a ketaminexylazine mixture (ip), allowing the subcutaneous implantation of mini-osmotic pumps (Alzet, model 2001). The pumps were filled with verapamil (Ver), isoproterenol (Iso), isoproterenol and verapamil (Iso ϩ Ver), or vehicle alone (0.02% ascorbic acid). Mice carrying drug-loaded minipumps are abbreviated as Iso, Ver, and Iso ϩ Ver for pumps containing isoproterenol, verapamil, or the two drugs together. Control animals carried minipumps with vehicle, and control animals were investigated in parallel with each set of experimental animals. (20) . No-reverse transcription controls were prepared for each sample and showed no amplification.
Western blots. Whole cell lysates were prepared from cells isolated from adult hearts treated for 48 h with Ver (n ϭ 5) or vehicle (n ϭ 4). SDS-PAGE (7.5% separating gel, Bio-Rad) and immunoblotting were carried out with routine protocols. Affinitypurified L-type Ca 2ϩ channel ␣-subunit polyclonal antibody at 2 g/ml antibody (D. Andres lab) was visualized with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (Chemicon) and Super Signal West Pico Chemiluminescence (Pierce). Each lane contained 10 g of total protein. All Western blot experiments were repeated at least three times to ensure that experimental observations were reproducible. Loading was confirmed by stripping (Restore Western Blot Stripping Buffer, Pierce) and reprobing blots with GAPDH monoclonal antibody (Ambion). Immunoblots were scanned on an Epson Perfection 1650 and quantified with densitometry (Scion Image, Scion).
Blood pressure and heart rate. Systolic and diastolic blood pressure (BP) and heart rate (HR) were measured in conscious, restrained mice with the Visitech Tailcuff System (Visitech Systems). BP parameters and heart weight-to-body weight ratios are shown in Table 1 . No significant difference was observed between background and vehicle groups for the aforementioned physiological parameters. Therefore, in Figs. 1-7 and Table 2 these data were combined and designated as the control group.
ECG. ECGs were measured noninvasively with an EC Genie (Mouse Specifics). Briefly, animals were placed on a gel electrode lead plate on the ECG recording platform. Animals were allowed to acclimate for 4 -10 min. After the acclimation period, ECG signals were recorded for 2-10 min. Raw ECG data were signal averaged across successive R-R intervals. As necessary, a cotton swab was used to gently move the animal's feet into a proper position on the lead plate for recording. Baseline ECGs were recorded before Ver exposure and daily after exposure. ECGs were recorded 24 h after administration. Mice then received an intraperitoneal injection of Iso (30 mg/kg) followed by immediate ECG measurement. ECG parameters in conscious mice were taken from averaged ECG data. Because there is some question on the exact location of the T wave, especially T wave termination, we operationally defined a T wave as shown in Fig. 7 : T is the first trough following the prominent QRS complex. Corrected QT interval (QTc) was calculated for mice following Mitchell et al. (35) .
Cell isolation procedures. Single ventricular myocytes were enzymatically isolated with a modified Alliance for Cellular Signaling protocol (PP00000125) at 48 h after pump implantation. Myocytes were isolated 48 h after minipump implantation to allow time for any changes in transcription to be reflected at the functional protein level. Briefly, mice were anesthetized and hearts were rapidly excised and retrogradely perfused at 3 ml/min and 37°C for 4 -8 min with a Ca 2ϩ -free bicarbonate-based perfusion buffer containing (mM) 113 NaCl, 4.7 KCl, 0.6 KH 2PO4, 1.2 MgSO 4, 0.6 NaH2PO4, 5.5 glucose, 12 NaHCO3, 10 KHCO3, 10 HEPES, 0.032 phenol red, 10 2,3-butanedione monoxime, and 30 taurine. The perfusion buffer was gassed with 95% O2-5% CO2 for at least 30 min before use. Enzymatic digestion began with 0.25 mg/ml liberase Blendzyme (Roche) and 12.5 M CaCl2 added to the perfusion buffer for ϳ13 min until the heart was swollen and pale in color. The heart was then cut from the cannula. Ventricular tissue was placed in a dish with enzyme buffer and gently dissociated for several minutes. After the addition of stop buffer (perfusion buffer containing 10% FBS and 12.5 M CaCl2), dissociation continued until large pieces of heart tissue were gently dispersed into the cell suspension. Cells were allowed to sediment by gravity for 10 min, followed by centrifugation at 180 rcf for 1 min. Cells were resuspended in perfusion buffer containing 5% FBS and 12.5 M CaCl 2. External Ca 2ϩ was added incrementally back to the solution to 2.0 mM. Only rod-shaped, quiescent myocytes with clear edges were selected for current recording.
Ca 2ϩ current measurements. Ca 2ϩ current was recorded from Ca 2ϩ -tolerant female mouse ventricular cells at 37°C 1-6 h after isolation. After establishment of whole cell configuration, the cells were perfused with Na ϩ -and K ϩ -free solution containing (mM) 140 N-methyl-D-glucamine, 1.0 MgCl2, 2.5 CaCl2, 10 HEPES, 10 glucose, and 5 4-aminopyridine at pH 7.4. Pipettes had tip resistances of 1-2 M⍀ after filling with pipette solution composed of (mM) 125 CsCl, 10 tetraethylammonium chloride Cl, 1.0 MgCl 2, 10 EGTA, 5 Mg-ATP, (Fig. 1) . This increase was independent of sex; it was not different in male compared with female mice.
Measurement of protein and ionic current is necessary to evaluate functionally active channel proteins. To allow sufficient time for protein expression, cells were isolated for Western blot analysis and Ca 2ϩ current measurement at 2 days after Ver pump implantation (2d-Ver). Western blot demonstrated a sixfold increase in Ca V 1.2 protein (Fig. 2) .
Functionally active channel protein was assessed with current-voltage (I-V) relationships for I Ca,L obtained by applying a series of 250-ms test pulses ranging from Ϫ40 to ϩ50 mV in 5-mV increments from a holding potential of Ϫ40 mV at 0.2-Hz frequency. To isolate cells, hearts are removed and cells are rinsed free of acute Ver exposure for at least 1 h and up to 6 h. Thus Ver refers to the pretreatment. Consistent with the prediction from mRNA and protein changes, basal I Ca,L from 2d-Ver mice was increased 1.4-fold relative to control mice (Fig. 3A) . The increase of current occurred without a shift of voltage dependence.
A common mechanism for an increase of I Ca,L is acute ␤-adrenergic stimulation (Fig. 3A) . Therefore we tested the response of I Ca,L to acute Iso perfusion (to avoid a potentially confusing nomenclature, we refer to the use of acute 1 M Iso perfusion of dispersed cells as acute-␤-stim). Acute-␤-stim is the immediate response of isolated cells to exposure of Iso with a duration of seconds. Cells from chronic Ver-treated animals responded to acute-␤-stim with a slight increase of maximal conductance (G max ) and slight negative shift of I-V relationship (Fig. 3, A and B) . The mean half-activation potentials (V 1/2 ) for basal conditions were not statistically significant and were Ϫ10.1 Ϯ 0.5 and Ϫ10.3 Ϯ 1.0 mV for control and Ver mouse groups, respectively.
Chronic ␤-adrenergic stimulation. Chronic Ver treatment increased HR and systolic BP ( Table 1 ). The increase of HR is consistent with a compensatory baroreflex response that includes a compensatory increase of sympathetic stimulation. Therefore, we explored the effect of chronic ␤-adrenergic stimulation by treatment with chronic Iso alone. Long-term Iso models are well established, although many previous studies used Iso treatment longer than 24 h (3, 12, 23, 30) . After 24 h of Iso infusion heart/body weight increased, no change was observed in systolic and diastolic BP, but HR increased compared with both vehicle and background (Table 1) . Ca v 1.2 mRNA levels were constant, whereas Rem levels increased twofold in hearts from 1d-Iso mice (Fig. 4) .
In Fig. 5A the peak values of I Ca,L are plotted against their respective test potentials for basal conditions compared with acute-␤-stim, and the data are fitted to a modified Boltzmann distribution. The response of I Ca,L to acute-␤-stim is eliminated by 2-day in vivo pretreatment. The maximal macroscopic conductance, manifested as the slope of the ascending limb of the I(V) curve, is significantly increased by acute-␤-stim in cells obtained from control animals, but it is unchanged in cells from Iso pump mice. Similarly, acute-␤-stim shifts the I(V) curve ϳ5 mV for control only. Figure 5B summarizes these effects, showing that G max of control cells was significantly increased during acute-␤-stim treatment (from 189 Ϯ 10 to 257 Ϯ 23 pS/pF; P Ͻ 0.005, n ϭ 15) while acute-␤-stim had no effect on the G max of cells obtained from 2d-Iso. The mean V 1/2 obtained was more negative in the presence of 1 M Iso, but the differences were not significant. This loss of acute-␤-stim responsiveness confirms previous observations of the response of I Ca,L to hypertrophic stimuli. As with 2d-Ver, Iso alone had no effect on I Ca,L kinetics.
To further examine the homeostatic regulation of the Ca 2ϩ channel we implanted pumps containing Ver and Iso in a single pump. Either Ver or Iso mice showed elevated HR, but Ver resulted in elevated BP. To counter this BP elevation we simultaneously infused mice with a combination of Iso ϩ Ver. This combination resulted in a decrease of both systolic and diastolic BP along with an increase in heart rate ( Table 1) . The Iso ϩ Ver treatment did not result in an increase in Ca V 1.2 mRNA expression such as that observed in the Ver mice (Fig. 6A) . No significant changes were observed in basal I Ca,L (Fig. 6B ) or single-cell capacitance (Fig. 6D ) compared with control. In addition, acute-␤-stim responsiveness was absent in these animals (Fig. 6C) ECG measurement. Ver increases Ca V 1.2 mRNA and protein and I Ca,L and blunts acute-␤-stim responsiveness of I Ca,L in isolated cells. To noninvasively investigate the effect of Ver on cardiac electrical activity, we evaluated the ECG from animals infused for 48 h with Ver, followed by a 24-h clearance period to reveal the functional consequences of Ca V 1.2 upregulation. ECG parameters in unrestrained Ver control mice are shown in Table 2 . No significant differences were observed between Ver and control mice (Fig. 7, A and B) . To mimic in vitro acute-␤-stim, we administered acute Iso via intraperitoneal injection. Control and Ver animals responded to acute-␤-stim with a prolonged R-R interval and an increase of amplitude of the P wave (Fig. 7, C and D) . Although acute-␤-stim slowing of HR is unusual for large mammals, similar acute responses to intraperitoneal Iso in control mice were observed with ECG in previous studies (Ref. 9; Table 2 ). Despite the finding that the mean PR, QT, and QTc intervals were not significantly changed, consideration of the acute-␤-stim effect on an animalby-animal basis (Fig. 7E ) revealed an interesting effect that tends to correlate with the in vitro I Ca,L recordings. Acute-␤-stim prolonged QT C in 80% (16/20) of control versus 41% (10/24) of Ver trials (P ϭ 0.14, Fisher's exact test).
DISCUSSION
The major finding of this study is that long-term blockade of I Ca,L by Ver increases I Ca,L in cardiac myocytes isolated from mature hearts. This is in contrast to the well-established finding that chronic application of Iso in vivo has no effect on basal I Ca,L but eliminates the acute ␤-adrenergic receptor-induced increase of I Ca,L . Ver treatment increases Ca V 1.2 mRNA and protein. In contrast, Iso has no effect on Ca V 1.2 mRNA but increases Rem (a negative regulator of Ca 2ϩ channel expression). Moreover, Iso in combination with Ver prevents the Ver-induced mRNA and I Ca,L increases. These data are consistent with the hypothesis that ventricular cardiac myocytes homeostatically regulate I Ca,L . Our data suggest that chronic CCB elicits a compensatory upregulation of mRNA and protein that coincides with an increased I Ca,L .
Persistent Ca 2ϩ channel blockade. To examine homeostatic regulation of the Ca 2ϩ channel in mouse ventricular myocardium, we implanted pumps containing Ver, which increased systolic BP and HR without affecting diastolic BP. Conversely, Ver is frequently used clinically to manage BP as a potent vasodilator. HR or pulse effects may be dependent on the mode of delivery and the pharmacokinetics of the Ca 2ϩ channel antagonist. Ver has been shown to have minimal effect on HR when delivered via intracoronary injection. However, intravenous infusion of Ver results in a reflex increase in HR (43) . To maintain cardiac output, HR would increase. In addition, vascular beds may constrict, increasing resistance in order to increase venous return. This increase in resistance would have a greater effect on systolic BP than diastolic BP (33) . Systolic function has been shown to be effected by three principal mechanisms: Frank-Starling (force-length), force-frequency relations, and adrenergic stimulation. All three play a role in humans and larger mammals when enhanced cardiac output is needed. However, current research suggests that force-frequency relations and adrenergic stimulation play only a minor role in this response in mice. These hemodynamic differences highlight the need for further experimentation on larger mammals but should not detract from the result that cardiac I Ca,L is homeostatically regulated.
Iso ϩ Ver resulted in a decrease of both systolic and diastolic BP with an increase in HR. Ver and Iso function to dilate vessels in both arterial and venous circulation, decreasing total peripheral resistance and venous return, resulting in a decrease in BP. As a compensatory response, HR increases. Alternatively, the HR increase could be the result of the direct effect of Iso on the heart. Despite mouse-human differences in hemodynamic function, similar trends were observed with Ver treatment in patients scheduled for coronary angiography (37) . Heart-to-body weight ratios were unchanged in Iso ϩ Ver and decreased in Ver-only pumps. Ver has been shown to prevent increases in heart-to-body weight ratio observed in hypertrophy models (34, 42) , and a decreased ventricular wet weight was demonstrated in chicken embryos treated with Ver (10). Despite similar, albeit unexpected, increases in HR by either Ver or Iso alone, Iso ϩ Ver antagonized the Ver-induced increase of Ca 2ϩ channels. Surprisingly, mRNA and protein levels of Ca V 1.2 (the main pore-forming subunit of the Ca 2ϩ channel) increased in Ver- treated mice (chronic Ca 2ϩ channel blockade). We also observed an increase in I Ca,L in Ver-treated mice. To our knowledge this is the first time an increase in Ca 2ϩ current expression has been reported in response to chronic Ca 2ϩ channel blockade. Iso ϩ Ver treatment prevented the mRNA increase of the GTPase Rem present in the Iso-treated animals, suggesting that the upregulation of Rem may be mediated through changes in I Ca,L . Ca V 1.2 and Ca V ␤ 2 expression levels of the Iso ϩ Ver-treated animals were similar to those observed with Iso alone.
The response of I Ca,L to acute-␤-stim was diminished in Iso ϩ Ver mice similar to the response observed in Iso mice. In Ver mice acute-␤-stim also resulted in a diminished responsiveness. Chronic treatment with ␤-adrenergic agonists results in loss of receptors from the cell surface and degradation of receptor protein leading to decreased receptor expression (40) .
␤-Adrenergic stimulation. In cardiac muscle, ␤-adrenergic stimulation increases HR, force of contraction, and relaxation rate. Chronic ␤-adrenergic stimulation, however, is commonly associated with hypertrophying heart in conditions such as heart failure. Our use of whole cell capacitance and acute Iso responsiveness measurements of cells dispersed from mice treated with Iso in vivo for periods as brief as 24 -48 h reflects a hypertrophic phenotype at the cellular level. We also observed an increase in heart/body weight and HR at 24 h. Fan et al. (16) examined the transcriptional regulation of L-type Ca 2ϩ channels in isolated rat myocytes. These in vitro studies observed coordinate regulation of Ca V 1.2, Ca V ␤ 2 , and ␣ 2 ␦. In vivo studies using whole animals are at odds with these in vitro findings, showing no change in Ca V 1.2 expression levels with treatment with Iso for up to 7 days (23); similarly, our results showed no change in Ca V 1.2 expression levels or Ca 2ϩ current after 24-h Iso treatment. Aside from increasing I Ca,L , Ca V ␤s play an important role in determining the behavior of L-type Ca 2ϩ channels. They function to increase surface expression of the Ca V 1.2 (␣-subunit) (8, 48) and produce hyperpolarizing shifts in the voltage dependence of channel activation. (5, 44) Rem has been shown to be a potent negative regulator of Ca 2ϩ channel function through ␤-subunit interaction (18) . We speculate that the change observed in auxiliary subunits at 24 h may function to maintain a constant Ca 2ϩ current. Chronic ␤-adrenergic stimulation eliminates the response of I Ca,L to acute Iso. Ver also eliminated I Ca,L responsiveness to acute-␤-stim, but the key difference was that Ver induced an increase of basal current, an increase of protein, and an increase of Ca V 1.2 mRNA that was not observed with Iso. It is possible that Ver activated a reflex response that increased sympathetic stimulation. However, Ver, in contrast to Iso, had selective effects on Ca 2ϩ channel regulation. ECG measurements. To evaluate the physiological implications of CCB we characterized ECG in control versus Ver and tested acute-␤-stim to parallel our in vitro studies. Although a selective increase of I Ca,L would be expected to prolong QT interval (27), we measured no significant change of QT or QTc. It must be emphasized that action potential repolarization, which underlies QT interval, is the result of a balance of I Ca,L and K ϩ currents. This balance is likely more delicate in humans and large mammals with longer plateau potentials. In the mouse transient outward K ϩ currents (I to ) such as that carried by K V 4.2 dominate repolarization, and knockout of K V 4.2 markedly prolongs QT interval (24) . It is plausible that the relatively large I to precludes observation of a 20% increase of I Ca,L in the mouse. Also, we cannot rule out the possibility that CCB triggered multiple compensatory responses, and this is a focus of ongoing studies. Finally, it should be remembered that an accurate measure of complete repolarization cannot be obtained from a mouse ECG (14) ; thus ECG data showing no apparent effect of the mean QT intervals should be cautiously interpreted.
Limitations. I Ca,L cannot be measured from cells in the intact heart. As a result, cells are removed from residual Ver blockade and channel reexpression may occur during isolation. For this scenario to obscure data interpretation requires that mechanisms of channel reexpression are different after CCB compared with control.
Studying I Ca,L responses to drugs administered to intact animals is vastly more complex than cell culture models. Heart cells can be isolated and cultured for durations similar to those in our studies. Studying in vitro cultured cells alleviates numerous confounding variables presented by hemodynamic regulation in an intact animal. On the other hand, cardiac myocytes in primary culture can dedifferentiate (17) . Thus it is impossible to know whether myocytes maintained in vitro reflect in vivo responses (16, 23) .
We selected only two Ca 2ϩ channel regulatory proteins for study in addition to the main pore-forming subunit. This sharply contrasts with genomic approaches that evaluate microarrays of cDNA for thousands of transcripts. Genomic approaches are a powerful tool to evaluate clusters of changes in response to stressors. However, omitting a single regulatory protein can skew microarray data interpretation. For example, while it is widely recognized that Ca V ␤ 2 increases I Ca,L , it is less well known that RGK proteins provide a robust block of I Ca,L expression (2, 18) . Thus it is imperative to determine ionic current levels (20) . Importantly, our study reinforces the principle that multiple proteins sum to set a level of Ca 2ϩ channel complex expression. Furthermore, assessment of mRNA levels as a readout of Ca 2ϩ channel function will always be limited by our inability to identify all proteins in the Ca 2ϩ channel complex (15) . Moreover, posttranslational modifications of Ca 2ϩ channels can dramatically alter I Ca,L levels.
Summary. The main results of this study are as follows. 1) Chronic Ca 2ϩ channel blockade significantly causes upregulation of Ca V 1.2 mRNA (the main pore-forming subunit) and results in an increase of Ca 2ϩ current. 2) Chronic in vivo ␤-adrenergic stimulation increases a negative (Rem) regulator of I Ca,L without changing I Ca,L levels. 3) Chronic Ca 2ϩ channel block by Ver antagonizes the Iso-induced upregulation of Rem. Hemodynamic differences between mice and humans make it difficult to extrapolate the data to clinical situations. However, the first point has rather important implications considering the widespread clinical use of CCBs. Our results suggest that cardiac myocytes from the ventricular chamber of the heart respond to long-term Ca 2ϩ channel block by increasing Ca 2ϩ channel current. These data may provide insight into mechanisms for arrhythmia and sudden death in patients with sporadic noncompliance of a CCB drug regiment. Future experiments are needed on larger mammals examining the potential for action potential dispersion as a result of transmural or regional differences in I Ca,L .
